1. Home
  2. TNXP vs JL Comparison

TNXP vs JL Comparison

Compare TNXP & JL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNXP
  • JL
  • Stock Information
  • Founded
  • TNXP 2007
  • JL 1985
  • Country
  • TNXP United States
  • JL Hong Kong
  • Employees
  • TNXP N/A
  • JL N/A
  • Industry
  • TNXP Biotechnology: Pharmaceutical Preparations
  • JL
  • Sector
  • TNXP Health Care
  • JL
  • Exchange
  • TNXP Nasdaq
  • JL NYSE
  • Market Cap
  • TNXP 19.5M
  • JL 10.1M
  • IPO Year
  • TNXP N/A
  • JL 2024
  • Fundamental
  • Price
  • TNXP $0.61
  • JL $3.03
  • Analyst Decision
  • TNXP Strong Buy
  • JL
  • Analyst Count
  • TNXP 2
  • JL 0
  • Target Price
  • TNXP $53.50
  • JL N/A
  • AVG Volume (30 Days)
  • TNXP 202.6M
  • JL 349.3K
  • Earning Date
  • TNXP 11-12-2024
  • JL 07-31-2024
  • Dividend Yield
  • TNXP N/A
  • JL N/A
  • EPS Growth
  • TNXP N/A
  • JL N/A
  • EPS
  • TNXP N/A
  • JL 0.26
  • Revenue
  • TNXP $11,291,000.00
  • JL $28,378,669.00
  • Revenue This Year
  • TNXP $62.53
  • JL N/A
  • Revenue Next Year
  • TNXP $26.17
  • JL N/A
  • P/E Ratio
  • TNXP N/A
  • JL $11.70
  • Revenue Growth
  • TNXP 183.05
  • JL N/A
  • 52 Week Low
  • TNXP $0.12
  • JL $0.23
  • 52 Week High
  • TNXP $14.08
  • JL $29.95
  • Technical
  • Relative Strength Index (RSI)
  • TNXP 75.02
  • JL 79.30
  • Support Level
  • TNXP $0.32
  • JL $2.64
  • Resistance Level
  • TNXP $0.72
  • JL $3.04
  • Average True Range (ATR)
  • TNXP 0.15
  • JL 0.32
  • MACD
  • TNXP 0.04
  • JL 0.17
  • Stochastic Oscillator
  • TNXP 39.61
  • JL 71.16

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

About JL J-LONG GROUP LIMITED

J-Long Group Ltd is an established distributor in Hong Kong of reflective and non-reflective garment trims including, among others, heat transfers, fabrics, woven labels and tapes, sewing badges, piping, zipper pullers and drawcords. It also offers a wide range of apparel solution services to cater to its customers' needs for reflective and non-reflective garment trims, ranging from market trend analysis, product design and development and production to quality control.

Share on Social Networks: